Human lymphadenitis due to Corynebacterium pseudotuberculosis: report of ten cases from Australia and review.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMID 9114145)

Published in Clin Infect Dis on February 01, 1997

Authors

M M Peel1, G G Palmer, A M Stacpoole, T G Kerr

Author Affiliations

1: Department of Microbiology, The University of Melbourne, Parkville, Victoria, Australia.

Articles citing this

The genus corynebacterium and other medically relevant coryneform-like bacteria. J Clin Microbiol (2012) 2.08

The pan-genome of the animal pathogen Corynebacterium pseudotuberculosis reveals differences in genome plasticity between the biovar ovis and equi strains. PLoS One (2013) 1.42

The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene-regulatory networks contributing to virulence. BMC Genomics (2010) 1.24

Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep. Infect Immun (1998) 1.02

Characterization of United Kingdom isolates of Corynebacterium pseudotuberculosis using pulsed-field gel electrophoresis. J Clin Microbiol (2000) 0.97

An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets. BMC Genomics (2015) 0.85

Corynebacterium pseudotuberculosis Pneumonia in a Veterinary Student Infected During Laboratory Work. Open Forum Infect Dis (2015) 0.83

Evaluation of ERIC-PCR as genotyping method for Corynebacterium pseudotuberculosis isolates. PLoS One (2014) 0.83

Mature Epitope Density--a strategy for target selection based on immunoinformatics and exported prokaryotic proteins. BMC Genomics (2013) 0.82

An infected hydrogel buckle with Corynebacterium pseudotuberculosis. Br J Ophthalmol (2005) 0.81

Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis. BMC Genomics (2014) 0.81

Genome Sequences of Corynebacterium pseudotuberculosis Strains 48252 (Human, Pneumonia), CS_10 (Lab Strain), Ft_2193/67 (Goat, Pus), and CCUG 27541. Genome Announc (2014) 0.80

Immunological characterization of diphtheria toxin recovered from Corynebacterium pseudotuberculosis. Saudi J Biol Sci (2015) 0.80

High sero-prevalence of caseous lymphadenitis identified in slaughterhouse samples as a consequence of deficiencies in sheep farm management in the state of Minas Gerais, Brazil. BMC Vet Res (2011) 0.79

The Corynebacterium pseudotuberculosis in silico predicted pan-exoproteome. BMC Genomics (2012) 0.78

Changes in protein abundance are observed in bacterial isolates from a natural host. Front Cell Infect Microbiol (2015) 0.76

Caprine abscess model of tulathromycin concentrations in interstitial fluid from tissue chambers inoculated with Corynebacterium pseudotuberculosis following subcutaneous or intrachamber administration. Antimicrob Agents Chemother (2013) 0.75

Vaccination against Corynebacterium pseudotuberculosis infections controlling caseous lymphadenitis (CLA) and oedematousskin disease. Saudi J Biol Sci (2016) 0.75

Exploration of Nitrate Reductase Metabolic Pathway in Corynebacterium pseudotuberculosis. Int J Genomics (2017) 0.75

Multiplex polymerase chain reaction to identify and determine the toxigenicity of Corynebacterium spp with zoonotic potential and an overview of human and animal infections. Mem Inst Oswaldo Cruz (2013) 0.75

Quadruplex PCR assay for identification of Corynebacterium pseudotuberculosis differentiating biovar Ovis and Equi. BMC Vet Res (2017) 0.75